Canine cognitive dysfunction looks a lot like Alzheimer’s and dementia in humans. Could a disease-modifying intervention that seems effective our furry companions also work for…
Bombshell exposé in Science magazine and follow-up reporting “make a mountain out of a molehill,” leading Alzheimer’s experts say. The media is reporting that…
Better Alzheimer’s treatments are going to require better models of Alzheimer’s brains in the lab, researchers say. Psychology researcher Étienne Aumont at the University…
Biogen and Eisai’s next disease-modifying Alzheimer’s drug candidate, lecanemab, has been granted FDA priority review, signaling that a decision could be made by early…
Longeveron’s investigational early-stage Alzheimer’s drug Lomecel-B, made from donated bone marrow, is enrolling participants for a clinical trial. Scientists have faced obstacle after obstacle…
Recent research shows that potentially preventable in-patient hospital admissions account for most of the cost of treatment for Native American adults living with dementia….
A Phase 2a clinical trial is underway to test the possible benefits of sodium selenate for people living with frontotemporal dementia. While Alzheimer’s is…